Elopiprazole
Elopiprazole can be used in study of neurological disease and SARS-CoV-2[1].
Product Specifications
CAS Number
[115464-77-2]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/elopiprazole.html
Solubility
10 mM in DMSO
Smiles
FC1=CC=C(C2=CC=C(CN3CCN(CC3)C4=CC=CC5=C4OC=C5)N2)C=C1
Molecular Formula
C23H22FN3O
Molecular Weight
375.44
References & Citations
[1]Crespo-Facorro B, et al. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol. 2021;12:646701. Published 2021 Mar 2. |[2]Crespo-Facorro B, et al. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol. 2021;12:646701. Published 2021 Mar 2. |[3]Crespo-Facorro B, et al. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol. 2021;12:646701. Published 2021 Mar 2.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1078051-01 0.02 mg (E-Coli)
Recombinant Oryza sativa subsp. indica Dehydrin Rab16B (RAB16B)
Ask
View Details 
MBS1078051-02 0.1 mg (E-Coli)
Recombinant Oryza sativa subsp. indica Dehydrin Rab16B (RAB16B)
Ask
View Details MBS1078051-03 0.02 mg (Yeast)
Recombinant Oryza sativa subsp. indica Dehydrin Rab16B (RAB16B)
Ask
View Details MBS1078051-04 0.1 mg (Yeast)
Recombinant Oryza sativa subsp. indica Dehydrin Rab16B (RAB16B)
Ask
View Details MBS1078051-05 0.02 mg (Baculovirus)
Recombinant Oryza sativa subsp. indica Dehydrin Rab16B (RAB16B)
Ask
View Details